Skip to main content

Meet the Analyst: Thomas Wakim & John Hester, Bell Potter Analyst

Bell Direct
December 17, 2024

Join us as we conclude our 2024 Meet the Analyst series with a bang. Our Market Analyst, Grady Wulff, sits down with Bell Potter’s analysts John Hester and Thomas Wakim for a comprehensive discussion on the healthcare sector.

From deciphering Neuren Pharmaceuticals (ASX:NEU) share price fluctuations to anticipating the news flow that will share 2025 guidance and identifying why Telix Pharmaceuticals (ASX:TLX) and Clarity Pharmaceuticals (ASX:CU6) are stocks to watch in the new year, John and Thomas cover it all in this final episode of the year.

In this video, John and Thomas discuss:

  • (1:48): the headwinds & tailwinds facing the healthcare sector
  • (7:10): why they are bullish on Neuren
  • (13:48): opportunities in healthcare stocks for 2025
  • (15:18): what’s on their clinical data radar for the upcoming year.

Morning Bell 19 April

Paulina Peters
April 19, 2022

Morning Bell 14 April

Paulina Peters
April 14, 2022

Morning Bell 13 April

Sophia Mavridis
April 13, 2022

Morning Bell 12 April

Paulina Peters
April 12, 2022

Morning Bell 11 April

Sophia Mavridis
April 11, 2022

Weekly Wrap 8 April

Sophia Mavridis
April 8, 2022

Morning Bell 7 April

Paulina Peters
April 7, 2022

Morning Bell 6 April

Paulina Peters
April 6, 2022

Morning Bell 5 April

Sophia Mavridis
April 5, 2022

Morning Bell 4 April

Sophia Mavridis
April 4, 2022

Weekly Wrap 1 April

Sophia Mavridis
April 1, 2022